Quetiapine and clozapine are antagonists of 5-HT2A receptors and dopamine D2 receptors, and this action is proposed as a key mechanism for their antipsychotic effects in schizophrenia without inducing parkinsonism [298–300]. The gene discussed is DRD2; the disease is Parkinson disease.